References
Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A; RECORD-1 Study Group.Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet. 2008 Aug 9;372(9637):449-56. Epub 2008 Jul 22
Marshall AT, Crisp AJ (2000) Reflex sympathetic dystrophy. Rheumatol (Oxford) 39(7):692–695
Molina MG, Diekmann F, Burgos D, Cabello M, Lopez V, Oppenheimer F, Navarro A, Campistol J (2008) Sympathetic dystrophy associated with sirolimus therapy. Transplantation 85(2):290
Vanacker A, Vandewiele I, Aerts P, De Groof J, Maes B (2007) Reflex sympathetic dystrophy in a renal transplant patient treated with sirolimus. Nephrol Dial Transplant 22(9):2709
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Massard, C., Fizazi, K., Gross-Goupil, M. et al. Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus. Invest New Drugs 28, 879–881 (2010). https://doi.org/10.1007/s10637-009-9295-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-009-9295-8